Post-chemotherapy residual mass in stage IIC seminomatous testicular tumor

Authors

N A. Ahmad, Aga Khan University
S R. Biyabani, Aga Khan University
Farhat Abbas, Aga Khan UniversityFollow

Document Type

Report

Department

Urology

Abstract

Introduction

The management of patients with residual masses following chemotherapy for advanced seminoma remains a difficult problem with no clear guidelines. While most patients with advanced seminoma achieve a complete or partial response with cisplatin based chemotherapy¹, a significant number will reveal a residual mass on follow up CT scan or MR imaging^2,3. Management options for post chemotherapy residual mass in a case of seminoma include close observation, radiation therapy and excisional surgery. While 80 to 85% of residual masses represent either fibrosis or necrotic tissue needing no further therapy, 10 to 15% may contain viable tumor which, if not recognized and effectively treated, may be lethal. A case of a stage II seminoma with post chemotherapy residual mass is presented and contemporary literature on this topic is reviewed.

Publication ( Name of Journal)

Journal of the Pakistan Medical Association

Recommended Citation

Ahmad, N. A., Biyabani, S. R., Abbas, F. (2002). Post-chemotherapy residual mass in stage IIC seminomatous testicular tumor. Journal of the Pakistan Medical Association, 83(12), 576-578.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_urol/29